Proactive Integration of Cybersecurity Measures throughout the Medical Device Lifecycle Deploying a Robust Cybersecurity Compliance Strategy to Meet FDA Expectations Engaging with HDOs to Optimize Cybersecurity in the Hospital Environment
Throughout the life science industry, development of medical products with connected components that link devices to online networks continues to increase. The need for a robust cybersecurity plan that safeguards the integrity of connected devices and the information shared within networks is therefore critical. Establishing a proactive strategy to tackle cyber threats, involving the inclusion of cybersecurity measures within initial product design as well as a robust process for vulnerability assessment and effective actions for necessary remediation, remains of the utmost importance. As organizations continue to increase cyber initiatives in the effort of providing continuously safe devices, the need for a well-trained, knowledgeable team intensifies accordingly to thwart vulnerabilities in both new and legacy devices.
The Q1 Productions 3rd Annual Medical Device Cybersecurity program will once more provide participants with an opportunity to dive deeper into the unique challenges facing device cybersecurity professionals, focusing on strategic risk mitigation and ongoing product safety. Coverage of FDA pre and post-market guidance and security expectations will provide a starting point for dialogue on device manufacturer and health delivery organization potential partnerships. Throughout the program, attendees will have an opportunity to hear from peers on key issues while connecting with cross-industry stakeholders from healthcare networks, government entities and non-profit organizations.
Eric Jahnke | Sr. Marketing Manager | Q1 Productions
312.955.0424 | email@example.com